BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Business

  XOMA Ltd. Restructures Drug Development Collaboration with Novartis Vaccines & Diagnostics, Inc. Including Oncology Drug Candidate HCD122

  November 10, 2008

   · 

  1 min read
• Drug Development

  DOR BioPharma, Inc. Receives Guidance From FDA on Proposed Confirmatory Phase 3 Clinical Trial Design of orBec(R) in GI GVHD

  November 10, 2008

   · 

  9 min read
• Business

  Orexigen Therapeutics, Inc. Names Eckard Weber Executive Chairman and Interim Chief Executive Officer

  November 10, 2008

   · 

  3 min read
• BioCapital

  US FDA Staff Question FDA, King Pharmaceuticals®, Inc. Data

  November 10, 2008

   · 

  1 min read
• Policy

  ReGen Biologics, Inc. 510(k) to be Considered by FDA Orthopaedic Panel

  November 10, 2008

   · 

  2 min read
• Drug Development

  Potentia Pharmaceuticals, Inc.’ Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial AMD Patients Treated with POT-4 Demonstrate No Adverse Toxic Effects

  November 10, 2008

   · 

  3 min read
• MGuard(TM), InspireMD Ltd.'s Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008

  November 10, 2008

   · 

  5 min read
• Business

  Isis Pharmaceuticals, Inc. Reports Financial Results and Highlights for Third Quarter of 2008 - Isis Ends the Third Quarter Profitable with More than $500 Million in Cash - Conference Call Webcast Monday, November 10, 8:30 a.m. EST at http://www.isispharm

  November 10, 2008

   · 

  12 min read
• Business

  New York City Mayor Bloomberg and Other Honorees Celebrate Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine

  November 10, 2008

   · 

  1 min read
• Santaris Pharma A/S Releases Positive Data on LNA-based Survivin Inhibitor

  November 10, 2008

   · 

  1 min read